AU8492398A - Telomere mimetic compounds and methods of use for same - Google Patents

Telomere mimetic compounds and methods of use for same

Info

Publication number
AU8492398A
AU8492398A AU84923/98A AU8492398A AU8492398A AU 8492398 A AU8492398 A AU 8492398A AU 84923/98 A AU84923/98 A AU 84923/98A AU 8492398 A AU8492398 A AU 8492398A AU 8492398 A AU8492398 A AU 8492398A
Authority
AU
Australia
Prior art keywords
telomere
methods
same
mimetic compounds
mimetic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU84923/98A
Inventor
Patrick L. Iverson
John E. Mata
Todd J. Page
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Nebraska
Original Assignee
University of Nebraska
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Nebraska filed Critical University of Nebraska
Publication of AU8492398A publication Critical patent/AU8492398A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
    • C12N15/1137—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing against enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/10—Type of nucleic acid
    • C12N2310/13—Decoys
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/30—Chemical structure
    • C12N2310/31—Chemical structure of the backbone
    • C12N2310/315—Phosphorothioates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/30—Chemical structure
    • C12N2310/33—Chemical structure of the base
    • C12N2310/336—Modified G
AU84923/98A 1997-07-17 1998-07-16 Telomere mimetic compounds and methods of use for same Abandoned AU8492398A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US5289297P 1997-07-17 1997-07-17
US60052892 1997-07-17
PCT/US1998/014763 WO1999003507A1 (en) 1997-07-17 1998-07-16 Telomere mimetic compounds and methods of use for same

Publications (1)

Publication Number Publication Date
AU8492398A true AU8492398A (en) 1999-02-10

Family

ID=21980600

Family Applications (1)

Application Number Title Priority Date Filing Date
AU84923/98A Abandoned AU8492398A (en) 1997-07-17 1998-07-16 Telomere mimetic compounds and methods of use for same

Country Status (2)

Country Link
AU (1) AU8492398A (en)
WO (1) WO1999003507A1 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7094766B1 (en) 1995-06-06 2006-08-22 Trustees Of Boston University Use of locally applied DNA fragments
US20030032610A1 (en) 1996-06-03 2003-02-13 Gilchrest Barbara A. Method to inhibit cell growth using oligonucleotides
EP2363133A1 (en) 2000-03-31 2011-09-07 Trustees of Boston University Composition comprising DNA fragments and medical and cosmetic uses thereof
ITRM20030475A1 (en) 2003-10-15 2005-04-16 Sipa Societa Industrializzazione P Rogettazione E PLANT AND METHOD FOR THERMAL CONDITIONING OF OBJECTS
WO2018221735A1 (en) * 2017-06-02 2018-12-06 富田製薬株式会社 Novel oligonucleotides

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5643890A (en) * 1995-01-31 1997-07-01 The Board Of Regents Of The University Of Nebraska Synthetic oligonucleotides which mimic telomeric sequences for use in treatment of cancer and other diseases

Also Published As

Publication number Publication date
WO1999003507A1 (en) 1999-01-28

Similar Documents

Publication Publication Date Title
AU3514299A (en) Method of providing secure user access
AU9790198A (en) Compounds and methods
EP1047426A4 (en) Use of methylnaltrexone and related compounds
AU8140898A (en) Inhibitors of beta-lactamases and uses therefor
AU4261697A (en) Compounds and methods
IL136308A0 (en) Antipicornaviral compounds and methods for their use and preparation
AU4009795A (en) Heterocyclic compounds and their use
AU2330599A (en) Fluorinated oxyvinyl compounds and methods of preparing and using same
AU2357397A (en) Stilbene compounds and their use
GB9418762D0 (en) Use of substituted cyclopentane-DI-and-triones
AU8479498A (en) Dual specificity phosphatase and methods of use
AU3118297A (en) Sok-1 and methods of use
HU9702480D0 (en) New polymorphe modification of doxazosin-mesylate
AU1451200A (en) Dual reporter system and methods of use therefor
AU4276496A (en) 3-Thioheteroaryl cephalosporin compounds, compositions and methods of use
AU2333099A (en) Aryloxyanilides and related compounds
AU8492398A (en) Telomere mimetic compounds and methods of use for same
AU2003204844A1 (en) Use of methylnaltrexone and related compounds
AU6328799A (en) Organophosphorous compounds and use thereof
HU9702479D0 (en) New polymorphe modification of doxazosin-mesylate
AU8333998A (en) New use of nociceptin
AU2152497A (en) Heterocyclic compounds and their preparation and use
EP1038021A4 (en) Compounds and methods for the inhibition of protein-protein interactions
AU2595297A (en) Use of aminoalkylcarboxylic derivatives
AU6196599A (en) Use of substituted 5-hydroxypyrazoles, novel 5-hydroxypyrazoles, methods for theproduction thereof and agents containing the same

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase